Login / Signup

What is needed to achieve HCV microelimination among HIV-infected populations in Andalusia, Spain: a modeling analysis.

Britt SkaathunAnnick BorquezAntonio Rivero-JuarezSanjay R MehtaFrancisco TellezManuel Castaño-CarracedoDolores MerinoRosario PalaciosJuan MacíasAntonio RiveroNatasha K Martin
Published in: BMC infectious diseases (2020)
Targeted scale-up of HCV treatment to PLWH can dramatically reduce prevalence among this group but will likely have little impact on the annual number of newly diagnosed HIV/HCV coinfections. HCV microelimination efforts among PWLH in Andalusia and settings where a large proportion of PLWH have a history of injecting drug use will require scaled-up HCV diagnosis and treatment among PLWH and the broader population at risk.
Keyphrases
  • hepatitis c virus
  • hiv infected
  • human immunodeficiency virus
  • antiretroviral therapy
  • newly diagnosed
  • hiv positive
  • risk factors
  • hiv aids
  • drug delivery
  • cancer therapy
  • hiv testing
  • smoking cessation